SALK NACHRICHTEN

Salk Institut für Biologische Studien - SALK NACHRICHTEN

Salk Nachrichten


Salk researchers awarded $2.5 million for innovative pancreatic cancer clinical trial

LA JOLLA—Salk Professor and HHMI Investigator Ronald Evans has been awarded $2.5 million by Stand Up To Cancer (SU2C) as part of a multi-institution team to conduct clinical studies to open up a new avenue for immunotherapy in the treatment of pancreatic Krebs. While the cancer normally excludes immune T-cells, the Evans lab discovered that modified vitamin D reprograms the cancer environment in a way that may allow the Merck drug Keytruda® to invade and destroy the tumor.


Can you hear me now? Ensuring good cellular connections in the brain

LA JOLLA—To have a good phone conversation, you need a good cellular connection. What's true for mobile phones also turns out to be true for neurons.


Salk neurobiologist receives NIH Director’s New Innovator award

LA JOLLA—Salk Institute Assistant Professor Eiman Azim has been named an NIH Director’s New Innovator for 2017 as part of the National Institutes of Health’s High-Risk, High-Reward Research Program. The award provides $1.5 million for a 5-year project during which Azim will explore how the nervous system controls dexterous movements.


Salk Institute Einnahmen steigen auf $134 Millionen im Fiskaljahr 2017

LA JOLLA — Das Salk Institute gab bekannt, dass die Gesamteinnahmen im Geschäftsjahr 2017 (1. Juli 2016 bis 30. Juni 2017) von $118 Millionen im Vorjahr auf $134 Millionen gestiegen sind, was einem Anstieg von 13,5 Prozent entspricht. Fast die Hälfte der Einnahmen, $62 Millionen, stammte von Spendern, darunter Stiftungsgeschenke und Zuschüsse sowie individuelle Geschenke und Vermächtnisse. Der Rest stammte aus staatlichen und unternehmerischen Finanzierungen sowie Zinseinnahmen.


Keynote address at the University of Queensland’s international scientific conference

Salk President Elizabeth Blackburn was invited to present the keynote address at the University of Queensland last month on gender equity and diversity issues in the Science, Technology, Engineering, Mathematics and Medicine (STEMM) disciplines. Blackburn is Australia’s first female Nobel laureate. Following her address, which received a positive audience response, she participated in a panel discussion on the barriers and challenges of women in science. Here is a transcript of her address:


Salk scientist Silvana Konermann named HHMI Hanna H. Gray Fellow

LA JOLLA—Silvana Konermann, a research associate in the lab of Helmsley-Salk Fellow Patrick Hsu, was chosen as one of 15 inaugural Howard Hughes Medical Institute Hanna H. Gray Fellows. Each fellow will receive up to $1.4 million in funding over eight years.


Der richtige Weg, DNA zu reparieren

LA JOLLA – Ist es besser, eine Aufgabe schnell zu erledigen und Fehler zu machen, oder sie langsam, aber perfekt zu erledigen? Wenn es darum geht, Brüche in der DNA zu reparieren, stehen Zellen vor der gleichen Wahl zwischen zwei Hauptreparaturwegen. Die Entscheidung ist wichtig, da die falsche Wahl noch mehr DNA-Schäden verursachen und zu Krebs führen könnte.


MicroRNA helps cancer evade immune system

LA JOLLA—The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor immunity.


Partnerschaft für ein gesundes Gehirn

LA JOLLA—Salk Institute scientists have discovered that an interaction between two key proteins helps regulate and maintain the cells that produce neurons. The work, published in Cell Stem Cell on September 14, 2017, offers insight into why an imbalance between these precursor cells and neurons might contribute to mental illness or age-related brain disease.


Elizabeth Blackburn, Salk Institute’s first female president, honored by ZEIT as a trailblazing woman

LA JOLLA—Salk Institute President Elizabeth Blackburn—the Institute’s first female president and one of only 12 women to have won a Nobel Prize in Physiology or Medicine—is among 46 honorees featured in FIRSTS, a new ZEIT multimedia project celebrating “women who broke ground in their fields” and “played pioneers in history,” the Salk Institute announced today.


Salk computational neurobiologist receives NSF grant to study how brain processes sound

LA JOLLA—Salk Associate Professor Tatyana Sharpee has been awarded a grant of approximately $950,000 over 4 years by the National Science Foundation to study how the brain processes complex sounds. This grant is part of a multi-national project together with groups in France and Israel.


Protein turnover could be clue to living longer

LA JOLLA—It may seem paradoxical, but studying what goes wrong in rare diseases can provide useful insights into normal health. Researchers probing the premature aging disorder Hutchinson-Gilford progeria have uncovered an errant protein process in the disease that could help healthy people as well as progeria sufferers live longer.


New kinds of brain cells revealed

LA JOLLA—Under a microscope, it can be hard to tell the difference between any two neurons, the brain cells that store and process information. So scientists have turned to molecular methods to try to identify groups of neurons with different functions.


Salk neuroscientist receives new NSF award to model the brain

LA JOLLA—As part of the National Science Foundation’s funding for new multidisciplinary approaches to neuroscience, Salk Professor Terrence Sejnowski together with the California Institute of Technology will receive over $1 million over 3 years to pursue advanced modeling of the brain.


Early gene-editing success holds promise for preventing inherited diseases

LA JOLLA—Scientists have, for the first time, corrected a disease-causing mutation in early stage human embryos with gene editing. The technique, which uses the CRISPR-Cas9 system, corrected the mutation for a heart condition at the earliest stage of embryonic development so that the defect would not be passed on to future generations.


Salk teams part of new effort to advance understanding of brain structure

LA JOLLA—Two Salk neuroscience labs are part of a National Science Foundation (NSF) effort to better understand the brain. Salk Professors Terrence Sejnowski und Ed Callaway are each collaborators in multi-institute projects awarded over $9 million apiece.


Salk Institute scientist Reuben Shaw receives National Cancer Institute Outstanding Investigator Award

LA JOLLA – Salk-Professor Reuben Shaw has received the National Cancer Institute (NCI) Outstanding Investigator Award (OIA), which encourages cancer research with breakthrough potential. Shaw, a member of Salk’s Molecular and Cell Biology Laboratory and holder of the William R. Brody Chair, will receive $4.2 million in direct funding over the next seven years to further his work. The award is granted, according to the NCI website, to innovative cancer researchers with outstanding records of productivity to allow them to take greater risks and be more adventurous in their research.


Salk scientists solve longstanding biological mystery of DNA organization

LA JOLLA—Stretched out, the DNA from all the cells in our body would reach Pluto. So how does each tiny cell pack a two-meter length of DNA into its nucleus, which is just one-thousandth of a millimeter across?


Wie pflanzliche Architekturen U-Bahn-Netzwerke nachahmen

LA JOLLA—It might seem like a tomato plant and a subway system don’t have much in common, but both, it turns out, are networks that strive to make similar tradeoffs between cost and performance.


Weitere Beweise deuten darauf hin, dass eine natürliche Pflanzenverbindung die geistigen Auswirkungen des Alterns reduzieren könnte

LA JOLLA—Salk scientists have found further evidence that a natural compound in strawberries reduces cognitive deficits and inflammation associated with aging in mice. The work, which appeared in the Journals of Gerontology Series A in June 2017, builds on the team’s previous research into the antioxidant fisetin, finding it could help treat age-related mental decline and conditions like Alzheimer’s or stroke.